Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
71.94 Up 2.64(3.81%) Jul 29, 4:00PM EDT
Prev Close:69.30
Open:69.55
Bid:50.00 x 100
Ask:115.00 x 100
1y Target Est:113.78
Beta:0.59
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:69.55 - 72.18
52wk Range:44.52 - 119.42
Volume:253,019
Avg Vol (3m):278,436
Market Cap:2.38B
P/E (ttm):N/A
EPS (ttm):-4.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GEVA

Comparison

Symbol% ChgMkt Cap
GEVAUp 3.81%2.38B
GILDUp 1.67%141.91B
MRKUp 1.05%171.19B
PFEDown 1.23%189.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):232.49
Ex-Dividend Date:30-Dec-08

Analysts

Annual EPS Est (Dec-14) :-5.93
Quarterly EPS Est (Jun-14) :-1.37
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback